A Texas wife has filed an Invokana wrongful death lawsuit on behalf of her deceased husband and blames drug makers Janssen Pharmaceuticals and Johnson & Johnson.

Plaintiff Cynthia F. is filling this Invokana wrongful death lawsuiton behalf of her late husband, Kenneth F. She believes that Janssen and Johnson & Johnson willfully concealed the dangerous risks of diabetes drug, Invokana.

In her Invokana wrongful death lawsuit, she claims that this willful concealment led to the death of her husband.

Kenneth was prescribed and ingested Invokana for his diabetes and suffered from myocardial infarction which Cynthia believes was a direct and proximate result of his Invokana use. This resulted in his death.

According to this Invokana wrongful death lawsuit, the plaintiff states that Invokana causes stroke, heart attack, severe kidney damage, diabetic ketoacidocis, respiratory failure and death.

What is Invokana?

Invokana is a drug used to treat type-2 diabetes, a disease that affects more than 29 million people in the United States. Often, medication can help control type-2 diabetes.

Invokana, generically known as canagliflozin, was approved in May 2013 by the Food and Drug Administration for the treatment of type-2 diabetes. In the first quarter of 2015, sales topped $278 million, making it one of Janssen’s most lucrative drugs.

It is what is called a SGLT-2 inhibitor, or sodium-glucose cotransporter 2 inhibitor. It is designed to inhibit renal glucose reabsorption with the goal of lowering blood glucose. According to this Invokana wrongful death lawsuit, as a result, excess glucose is not metabolized.

Instead, it is excreted through the kidneys. Unfortunately, diabetes patients are already at risk for kidney complications.

But in 2015, the FDA issued a safety warning about the negative risks associated with Invokana use. Specifically, the FDA adverse events reports include diabetic ketoacidosis and kidney disease.

An analysis of the FDA adverse events reports indicate that those patients who take Invokana are several times more likely to experience ketoacidosis than those who do not take Invokana.

Cynthia’s Invokana wrongful death lawsuit claims that Invokana was defective and unsafe for use and that any warnings on the labels were insufficient to warn consumers of the dangerous risks and reactions associated with Invokana.

The lawsuit claims that the defendants negligently and recklessly labeled, distributed and promoted their diabetes drug, Invokana, and that they had a duty to warn Cynthia’s husband, Kenneth, of the inherent risks associated with the drug.

In this Invokana wrongful death lawsuit, Cynthia is bringing this action for serious permanent injuries suffered because her husband took Invokana. She seeks compensatory and punitive damages, monetary restitution, equitable relief and attorneys’ fees.

She brings forth claims of design defect, failure to warn, common law negligence, gross negligence, breach of express warranty, breach of implied warranty, fraudulent misrepresentation, negligent misrepresentation, negligent design, fraudulent concealment, fraud, loss of consortium and wrongful death.

The Invokana Wrongful Death Lawsuit is Case No. 4:16-cv-03737, in U.S. District Court for the Southern District of Texas, Houston Division.